[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 2016

Predicting the Risk of Melanoma

Author Affiliations
  • 1Department of General Practice, Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, Australia
  • 2Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
JAMA Dermatol. 2016;152(8):875-877. doi:10.1001/jamadermatol.2016.1574

The incidence of cutaneous melanoma is growing worldwide; age-adjusted incidence rates have been increasing in most fair-skinned populations for several decades. In the United States, 150 000 cases per year are projected by 2030.1 Although melanoma has relatively good survival rates, it remains a major cause of cancer deaths and, as the most common cancer in young adults, it contributes to significant premature loss of life. The American Cancer Society estimates 10 130 melanoma deaths in the United States in 2016. Primary prevention and early detection are important strategies to reduce the burden of melanoma, but questions remain about where to focus such efforts.